COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,871 Articles (22,568 medRxiv, 8,303 bioRxiv)

Most recent first Previous |  Page 1620: Articles 16191-16200  | Next

Half year longitudinal seroprevalence of SARS-CoV-2-antibodies and rule compliance in German hospital employees
Herzberg, J., Vollmer, T., Fischer, B., Becher, H., Becker, A.-K., Sahly, H., Honarpisheh, H., Guraya, S. Y., Strate, T., Knabbe, C.
10.1101/2021.03.29.21254538 — Posted: 2021-03-31
SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Pediatric Rheumatology Database in Germany
Sengler, C., Eulert, S., Niewerth, M., Minden, K., Horneff, G., Kuemmerle-Deschner, J. B., Siemer, C., Berendes, R., Girschick, H., Huehn, R., Borte, M., Hospach, A., Emminger, W., Armann, J. P., Klein, A., Kallinich, T.
10.1101/2021.03.28.21254496 — Posted: 2021-03-31
Coping with COVID-19 Pandemic: A Population-Based Study in Bangladesh
Hossain, K. M. A., Saunders, K., Sakel, M., Walton, L. M., Raigangar, V., Uddin, Z., Hossain, M. A., Islam, A., Ahmed, F., Faruqui, R., Tasnim, T., Rana, S., Rubayet, S., Ahmed, M. S., Haque, M. O., Kabir, M. F., Hossain, M. S., Jahid, I. K., Yeasmin, M. H., Chakrovorty, S. K., Hossain, M. S., Paul, J.
10.1101/2021.03.30.21254632 — Posted: 2021-03-31
Why did the children stop coming? Reasons for paediatric emergency department attendance decrease during the first wave of the COVID-19 pandemic in the United Kingdom: A qualitative study
Breckons, M., Thorne, S. J., Walsh, R., Bhopal, S. S., Owens, S., Rankin, J.
10.1101/2021.03.30.21254661 — Posted: 2021-03-31
Adverse Events Following SARS-CoV-2 mRNA Vaccination Among Patients with Inflammatory Bowel Disease
Botwin, G., Li, D., Figueiredo, J., Cheng, S., Braun, J., McGovern, D. P. B., Melmed, G.
10.1101/2021.03.30.21254607 — Posted: 2021-03-31
Assessing the impact of multiple comorbidities on fatal outcome in young COVID-19
Monroy Castillero, P., Friedman, E., Revuelta Herrera, A., Yochelis, A.
10.1101/2021.03.29.21254599 — Posted: 2021-03-31
Upregulated miR-200c may increase the risk of obese individuals to severe COVID-19
Bellae Papannarao, J., Schwenke, D., Manning, P. J., Katare, R.
10.1101/2021.03.29.21254517 — Posted: 2021-03-31
Non-severe SARS-CoV-2 infection is characterised by very early T cell proliferation independent of type 1 interferon responses and distinct from other acute respiratory viruses.
Chandran, A., Rosenheim, J., Nageswaran, G., Swaddling, L., Pollara, G., Gupta, R., Guerra-Assuncao, J. A., Woolston, A., Ronel, T., Pade, C., Gibbons, J., Sanz-Magallon Duque De Estrada, B., Robert de Massy, M., Whelan, M., Semper, A., Brooks, T., Altmann, D. M., Boyton, R. J., McKnight, A., Manisty, C., Treibel, T. A., Moon, J., Tomlinson, G. S., Maini, M. K., Chain, B. M., Noursadeghi, M., COVIDsortium investigators
10.1101/2021.03.30.21254540 — Posted: 2021-03-31 Discussion: Onsite
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection
Marchi, S., Simonetta, V., Remarque, E., Ruello, A., Bombardieri, E., Bollati, V., Milani, G., Manenti, A., Lapini, G., Rebuffat, A., Montomoli, E., Trombetta, C.
10.1101/2021.03.29.21254534 — Posted: 2021-03-31
Efficacy and safety of convalescent plasma and intravenous immunoglobulin in critically ill COVID-19 patients. A controlled clinical trial.
Beltran Gonzalez, J. L., Gonzalez Gamez, M., Mendoza Enciso, E. A., Esparza Maldonado, R. J., Hernandez Palacios, D., Duenas Campos, S., Ovalle Robles, I., Macias Guzman, M. J., Garcia Diaz, A. L., Gutierrez Pena, C. M., Reza Escalera, A. L., Tiscareno Gutierrez, M. T., Galvan Guerra, E., Dorantes Morales, M. d. R., Martinez Medina, L., Monroy Colin, V. A., Arreola Guerra, J. M.
10.1101/2021.03.28.21254507 — Posted: 2021-03-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).